F-STAR THERAPEUTICS, INC. Proceeds from Common Stock Issued
F-STAR THERAPEUTICS, INC. reported Proceeds from Common Stock Issued of $2.31 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfCommonStock · last filed 2022-11-10
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2022-09-30 was $41.00K, a 1950.00% increase year-over-year.
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2022-06-30 was $320.00K.
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2022-03-31 was $1.95M.
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for the quarter ending 2021-12-31 was $1.05M.
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2021 was $78.35M.
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2018 was $37.96M, a 4.32% decline from fiscal 2017.
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2017 was $39.67M.
- F-STAR THERAPEUTICS, INC. proceeds from issuance of common stock for fiscal 2015 was $19.89M.
| Period end | Proceeds from Issuance of Common Stock 3 month | Proceeds from Issuance of Common Stock 6 month | Proceeds from Issuance of Common Stock 9 month | Proceeds from Issuance of Common Stock 9 month as first filed | Proceeds from Issuance of Common Stock 12 month |
|---|---|---|---|---|---|
| 2022-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $361.00K derived: sum of 2 quarters · filed 2022-11-10 | $2.31M 10-Q · filed 2022-11-10 | $3.36M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-06-30 | $320.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $2.27M 10-Q · filed 2022-08-11 | $3.32M derived: sum of 3 quarters · filed 2022-08-11 | $3.32M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2022-03-31 | $1.95M 10-Q · filed 2022-05-10 | $3.00M derived: sum of 2 quarters · filed 2022-05-10 | $3.00M derived: sum of 3 quarters · filed 2022-11-10 | ||
| 2021-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $1.05M derived: sum of 2 quarters · filed 2022-11-10 | $78.35M 10-K · filed 2022-03-15 | ||
| 2021-09-30 | $2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $77.30M 10-Q · filed 2022-11-10 | |||
| 2021-06-30 | $77.29M 10-Q · filed 2022-08-11 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-13 | ||||
| 2018-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $37.96M 10-K · filed 2020-02-14 | |||
| 2018-09-30 | $37.96M 10-Q · filed 2019-11-07 | ||||
| 2017-12-31 | $103.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11 | -$2.83M derived: sum of 2 quarters · filed 2019-03-11 | $39.67M 10-K · filed 2019-03-11 | ||
| 2017-09-30 | -$2.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-25 | $39.57M 10-Q · filed 2018-10-25 | $42.50M 10-Q · filed 2017-10-31 | ||
| 2017-06-30 | $42.50M 10-Q · filed 2018-08-02 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | $11.34M 10-Q · filed 2017-10-31 | |||
| 2016-06-30 | $11.34M 10-Q · filed 2017-07-31 | ||||
| 2015-12-31 | -$1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | -$1.75M derived: sum of 2 quarters · filed 2017-02-14 | -$1.75M derived: sum of 3 quarters · filed 2017-02-14 | $19.89M 10-K · filed 2017-02-14 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $0.00 derived: sum of 2 quarters · filed 2016-10-28 | $21.65M 10-Q · filed 2016-10-28 | ||
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01 | $21.65M 10-Q · filed 2016-08-01 | |||
| 2015-03-31 | $21.65M 10-Q · filed 2016-06-15 |